Cardiol Therapeutics Inc.

Develops oral cannabidiol therapies for inflammatory and fibrotic heart diseases.

CRDL | NDAQ

Overview

Corporate Details

ISIN(s):: CA14161Y2006
LEI:
Country:: United States of America
Address:: 602-2265 UPPER MIDDLE ROAD EAST, OAKVILLE
Website:: https://www.cardiolrx.com/
Sector:: Mining and quarrying
Industry:: Mining of non-ferrous metal ores

Description

Cardiol Therapeutics Inc. is a clinical-stage life sciences company focused on the research and clinical development of novel anti-inflammatory and anti-fibrotic therapies for the treatment of heart disease. The company develops treatments for underserved cardiovascular conditions, with a primary focus on pericarditis, myocarditis, and heart failure. Its lead product candidate, CardiolRx™, is an orally administered cannabidiol solution designed to target the underlying mechanisms of inflammation and fibrosis in cardiac disease. The company's pipeline also includes preclinical candidates. Cardiol Therapeutics collaborates with international research centers and clinical experts to advance its therapeutic programs for patients with debilitating heart conditions.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Quick Filters:

Filters

Filing Type

Language

Start date

End date

Clear

Bulk Actions:

	Date	Filing	Language	Size	Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Cardiol Therapeutics Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Cardiol Therapeutics Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Request This Data

Need More History? Access decades of standardized financials for Cardiol Therapeutics Inc. via our API.

Get Historical Data →

Insider Transactions

Date	Insider Name	Position	Type	Shares	Value
No insider transactions recorded for this company.

Peer Companies

Company	Country	Ticker
PC İLETİŞİM VE MEDYA HİZMETLERİ SANAYİ TİCARET A.Ş. Integrated media group providing data-driven advertising and media solutions for global brands.	Türkiye	PCILT
PDS Biotechnology Corp Developing T-cell activating immunotherapies for cancer and infectious diseases.	United States of America	PDSB
Peers Co.,Ltd. Accelerating tech adoption with consulting, HR services, and proprietary IT/AI solutions.	Japan	7066
PepGen Inc. Biotech using an EDO platform to treat genetic neuromuscular & neurological diseases.	United States of America	PEPG
PeptiDream Inc. Discovers peptide therapeutics via a proprietary platform and markets radiopharmaceuticals.	Japan	4587
Perion Network Ltd. AI-powered ad tech delivering omnichannel solutions for advertisers and publishers.	United States of America	PERI
PharmaCyte Biotech, Inc. Developing encapsulated cell therapies for targeted cancer and diabetes treatments.	United States of America	PMCB
PharmaLundensis AB Develops treatments for heavy metal toxicity and serious respiratory illnesses.	Sweden	PHAL
Pharos iBio Co., Ltd. AI-powered drug development for rare and refractory diseases, focusing on oncology.	South Korea	388870
PhoenixBio Co.,Ltd. CRO providing humanized liver mouse models and testing services for preclinical drug development.	Japan	6190